Safety of nelotanserin in a randomized placebo-controlled phase 2 study

Authors
Category Primary study
ConferenceMovement Disorders
Year 2016
This article has no abstract
Epistemonikos ID: bfe679dd02cb3f63d24c6a401898d4ab39114010
First added on: Apr 29, 2026